Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Alliance Sensors Group introduces SC-200 LVDT signal conditioner April 8, 2019 JSW Energy to focus on profitability, not costly acquisitions July 23, 2017 The 3 C's of Machine Safety September 4, 2018